United States. Securities and Exchange Commission
Israeli enterprise security company CyberArk Software Inc. is moving closer to its secondary offering on Wall Street, with plans to sell 4 million shares worth $240 million. The company's largest shareholder, Jerusalem Venture Partners (JVP), will sell shares worth $115 million and retain a 30.3% holding. Goldman
United States. Securities and Exchange Commission
Alliance Fiber Optic Products Inc., a leading manufacturer of optical networking components, has submitted a significant SEC filing, providing insight into the company's management structure and ownership. The filing, made on February 17, 2015, reveals information on the company's directors, officers, and owners of more than
United States. Securities and Exchange Commission
Kyocera Corp., a leading global electronics company, filed a U.S. Securities and Exchange Commission (SEC) form SC 13G on February 12, 2015, providing detailed information about its shareholder activity. The filing, which carries an SIC code of 3674 for Semiconductors and Related Devices, includes a single document with the
United States. Securities and Exchange Commission
Plexus Corp., a leading manufacturer of printed circuit boards, has submitted a filing to the U.S. Securities and Exchange Commission (SEC) detailing the shareholdings of its executive officers. The form 4 filing, made on February 6, 2015, provides insight into the company's leadership structure and executive compensation.
United States. Securities and Exchange Commission
A U.S. Securities and Exchange Commission filing by Sunedison, Inc. (Form 3) was posted on February 9, 2015. The filing is a formal document that discloses the beneficial ownership of securities held by the company's directors, officers, and owners of more than ten percent of a class
United States. Securities and Exchange Commission
Scana Corp., a U.S. company providing electric and other services, has submitted a Securities and Exchange Commission (SEC) filing, notifying investors of material events and corporate changes. The filing, dated February 4, 2015, lists the company's SIC code as 4931, Electric and Other Services Combined. The filing
United States. Securities and Exchange Commission
Edison International, a leading electric utility company in the US, reported a material event in a Securities and Exchange Commission (SEC) filing on February 3, 2015. The filing, which is a "current report" that provides real-time information on corporate changes and material events, was submitted by the company
United States. Securities and Exchange Commission
St Jude Medical Inc. submitted a U.S. Securities and Exchange Commission (SEC) filing on January 28, 2015, indicating the occurrence of material events or corporate changes that had not been previously reported. The filing, marked by Form 8-K, contains seven documents detailing the company's updates. As a
United States. Securities and Exchange Commission
Arrhythmia Research Technology Inc. has filed a Securities and Exchange Commission (SEC) filing SC 13G on January 26, 2015, with the SIC code 3845, Electromedical and Electrotherapeutic Apparatus. The filing contains one document and has the SEC file number 0001157523-15-000195. The company's contact information is provided as 25
United States. Securities and Exchange Commission
Lawyers Willie Briscoe and Patrick Powers, representing firms The Briscoe Law Firm, PLLC and Powers Taylor LLP, are investigating the sale of Entropic Communications, Inc. to MaxLinear, Inc. The proposed transaction entails Entropic shareholders receiving $1.20 in cash and 0.22 of MXL stock for each share owned. However,
United States. Securities and Exchange Commission
Advanced Micro Devices Inc. publicly disclosed a significant development through a U.S. Securities and Exchange Commission (SEC) filing on January 20, 2015. The filing, denoted as Form 8-K, is a critical report used to notify investors and security holders about material events or corporate changes that have not been
United States. Securities and Exchange Commission
Allergan Inc., a leading pharmaceutical company, has submitted a Securities and Exchange Commission (SEC) filing (Form 8-K) on January 12, 2015, pertaining to material corporate changes that may affect investors or security holders. This filing provides more current information on specified events than the company's quarterly or annual
